Finecure treats regulatory compliance and quality assurance as core to the business. Facilities operate under a quality management system built on Quality by Design principles, engineered to meet the standards of international health authorities and to give CDMO and P2P partners a pharmacopoeial-grade pedigree.
Finecure receives partner and customer audit requests at all sites. Audits may be conducted on paper, on site, or by a third party appointed by the partner. Documentation is provided in advance so that an audit team arrives prepared rather than discovering the quality system on the day.
Quality is built into the product lifecycle from inception. Quality Assurance teams apply proactive Quality by Design (QbD) principles to optimise manufacturing processes, ensuring consistent therapeutic delivery and structural integrity across large production volumes.
